Genetic factors related to unconjugated hyperbilirubinemia amongst adults

Pharmacogenetics and Genomics

Volumn 15, Issue 1, 2005, Pages 43-50

  Huang, Ching Shan ^a,b   Huang, May Jen ^b   Lin, Min Shung ^b   Yang, Sien Sing ^b   Teng, Hsiu Chen ^a   Tang, Kung Sheng ^a  

^a FOOYIN UNIVERSITY   (Taiwan)

^b CATHAY GENERAL HOSPITAL   (Taiwan)

Author keywords

G6PD deficiency; haplotypes; OATP2 gene; UGT1A1 gene; unconjugated hyperbilirubinemia

Indexed keywords

BILIRUBIN URIDINE DIPHOSPHOGLUCURONOSYL TRANSFERASE 1A1; BILIRUBIN URIDINE-DIPHOSPHOGLUCURONOSYL TRANSFERASE 1A1; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUCURONOSYLTRANSFERASE; ORGANIC ANION TRANSPORTER 2;

ADULT; ARTICLE; CASE CONTROL STUDY; FEMALE; GENETICS; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HYPERBILIRUBINEMIA; LIVER; MALE; METABOLISM; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK; RISK FACTOR;

ADULT; CASE-CONTROL STUDIES; FEMALE; GENOTYPE; GLUCOSEPHOSPHATE DEHYDROGENASE; GLUCURONOSYLTRANSFERASE; HAPLOTYPES; HETEROZYGOTE; HOMOZYGOTE; HUMANS; HYPERBILIRUBINEMIA; LIVER; MALE; MIDDLE AGED; MUTATION; ODDS RATIO; ORGANIC ANION TRANSPORT POLYPEPTIDE C; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK FACTORS;

EID: 21944437618     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/01213011-200501000-00007     Document Type: Article

References (36)

1. Cui Y, Konig J, Leier I, Buchholz U, Keppler D. Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6. J Biol Chem 2001; 276:9626-9630.
2. Clarke DJ, Moghrabi N, Monaghan G, Cassidy A, Boxer M, Hume R, et al. Genetic defects of the UDP-glucuronosyltransferase 1 (UGT1) gene that cause familial non-hemolytic unconjugated hyperbilirubinaemias. Clin Chim Acta 1997; 266:63-74.
3. Bosma PJ, Chowdhury JR, Bakker CT, Gantla S, de Boer A, Oostra BA, et al. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med 1995; 333:1171-1175.
4. Monaghan G, Ryan M, Seddon R, Hume R, Burchell B. Genetic variation in bilirubin UDP-glucuronosyltransferase gene promoter and Gilbert's syndrome. Lancet 1996; 347:578-581.
5. Sato H, Adachi Y, Koiwai O. The genetic basis of Gilbert's syndrome. Lancet 1996; 347:557-558.
6. Hsieh SY, Wu YH, Lin DY, Chu CM, Wu M, Liaw YF. Correlation of mutation analysis to clinical features in Taiwanese patients with Gilbert's syndrome. Am J Gastroenterol 2001; 96:1188-1193.
7. Huang CS, Luo GA, Huang MJ, Yu SC, Yang SS. Variations of the bilirubin uridine-diphosphoglucuronosyl transferase 1 A1 gene in healthy Taiwanese. Pharmacogenetics 2000; 10:539-544.
8. Chowbay B, Kanaga S, Gao F, Kei SK, Edmund JDL. Genetic polymorphisms of UDP-glucuronosyltransferase in Asians: UGT1A1*28 is a common allele in Indians. Pharmacogenetics 2002; 12:81-83.
9. Akaba K, Kimura T, Sasaki A, Tanabe S, Ikegami T, Hashimoto M, et al. Neonatal hyperbilirubinemia and mutation of the bilirubin uridine-diphosphate-glucuronosyltransferase gene: a common missense mutation among Japanese, Koreans and Chinese. Biochem Mol Biol Int 1998; 46:21-26.
10. Ando Y, Chida M, Nakayama K, Saka H, Kamataki T. The UGT1A1 *28 allele is relatively rare in a Japanese population. Pharmacogenetics 1998; 8:357-360.
11. Saeki M, Saito Y, Jinno H, Tohkin M, Kurose K, Kaniwa S, et al. Comprehensive UGT1A1 genotyping in a Japanese population by pyrosequencing. Clin Chem 2003; 49:1182-1185.
12. Monaghan G, Foster B, Jurima-Romet M, Hume R, Burchell B, Owens IS. UGT1 *1 genotyping in a Canadian Inuit population. Pharmacogenetics 1997; 7:153-156.
13. Beutler E, Gelbart T, Demina A. Racial variability in the UDP-glucuronosyl-transferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism? Proc Natl Acad Sci USA 1998; 95:8170-8174.
14. Beutler E. G6PD deficiency. Blood 1994; 84:3616-3636.
15. Tirona RG, Leake BF, Merino G, Kim RB. Polymorphisms in OATP-C: identification of multiple allele variants associated with altered transport activity among European- and African-Americans. J Biol Chem 2001; 276:35669-35675.
16. Nozawa T, Nakajima M, Tami I, Noda K, Nezu J, Sai Y, et al. Genetic polymorphisms of human organic anion transporter OATP-C (SLC21A6) and OATP-B (SLC21A9): allele frequencies in the Japanese population and functional analysis. J Pharmacol Exp Ther 2002; 302:804-813.
17. Yohei N, Ichiro I, Hiroshi S, Miyuki K, Kiyoshi K, Takeshi H, et al. Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: consequences for pravastatin pharmacokinetics. Clin Pharmacol Ther 2003; 73:554-565.
18. Huang MJ, Yang YC, Yang SS, Lin MS, Chen ES, Huang CS. Coinheritance of variant UDP-glucuronosyl transferase 1A1 gene and glucose-6-phosphate dehydrogenase deficiency in adults with hyperbilirubinemia. Pharmacogenetics 2002; 12:663-666.
19. Huang CS, Hung KL, Huang MJ, Li YC, Liu TH, Tang TK. Neonatal jaundice and molecular mutations in glucose-6-phosphate dehydrogenase deficient newborn infants. Am J Hematol 1996; 51:19-25.
20. Huang CS, Chang PF, Huang MJ, Chen ES, Chen WC. Glucose-6-phosphate dehydrogenase deficiency, the UDP-glucuronosyltransferase 1A1 gene and neonatal hyperbilirubinemia. Gastroenterology 2002; 123:127-133.
21. Huang MJ, Kua KE, Teng HC, Tang KS, Weng HW, Huang CS. Risk factors for severe hyperbilirubinemia in neonates. Pediatr Res 2004; 56:682-689.
22. Tang TK, Huang CS, Huang MJ, Tam KB, Yen CH, Tang CJC. Diverse point mutations result in glucose-6-phosphate dehydrogenase (G6PD) polymorphism in Taiwan. Blood 1992; 79:2135-2140.
23. Department of Health, Taiwan. Leading Cause of Death from Cancer. Health and Vital Statistics. Taipei: Department of Health, Taiwan; 2002, pp. 73-77.
24. Tamai I, Nezu J, Uchino H, Sai Y, Oku A, Shimane M, et al. Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family. Biochem Biophys Res Commun 2000; 273:251-260.
25. Yamamoto K, Sato H, Fujiyama Y, Doida YU, Bamba T. Contribution of two missense mutations (G71R and Y486D) of the bilirubin UDP glycosyltransferase (UGT1A1) gene to phenotypes of Gilbert's syndrome and Crigler-Najjar syndrome type II. Biochem Biophys Acta 1998; 1406:267-273.
26. Lo YS, Lu CC, Chiou SS, Chen BH, Chang JG. Molecular characterization of glucose-6-phosphate dehydrogenase deficiency in Chinese infants with or without severe neonatal hyperbilirubinemia. Br J Hematol 1993; 86:858-862.
27. Chen HL, Huang MJ, Huang CS, Tang TK. Two novel glucose-6-phosphate dehydrogenase deficiency mutations and association of such mutations with F8C/G6PD haplotype in Chinese. J Formosan Med Assoc 1997; 96:779-783.
28. Yu MW, Hsiao KJ, Wuu KD, Chen CJ. Association between glucose-6-phosphate dehydrogenase deficiency and neonatal jaundice. Int J Epidemiol 1992; 21:947-952.
29. Cappellini MD, Di Montemuros FM, Sampietro M, Tavazzi D, Fiorelli G. The interaction between Gilbert's syndrome and G6PD deficiency influences bilirubin levels. Br J Haematol 1999; 104:928-929.
30. Wang P, Kim RB, Chowdhury R, Wolkoff AW. The human organic anion transport protein SLC21A6 is not sufficient for bilirubin transport. J Biol Chem 2003; 278:20695-20699.
31. Mikko N, Elke S, Thomas L, Martin FF, Mikko N, Carl K, et al. High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1). Pharmacogenetics 2004; 14:429-440.
32. Watchko JF. Genetics and the risk of neonatal hyperbilirubinemia. Pediatr Res 2004; 56:677-678.
33. Persico M, Persico E, Bakker CTM, Rigato I, Amoroso A, Torella R, et al. Hepatic uptake of organic anions affects the plasma bilirubin level in subjects with Gilbert's syndrome mutations in UGT1A1. Hepatology 2001; 33:627-632.
34. Burchell B. Genetic variation of human UDP-glucuronosyltransferase: implications in disease and drug glucuronidation. Am J Pharmacogenomics 2003; 3:37-52.
35. Guillemette C. Pharmacogenomics of human UDP-glucuronosyltransferase enzymes. Pharmacogenomics J 2003; 3:136-158.
36. Kim RB. Organic anion-transporting polypeptide (OATP) transporter family and drug disposition. Eur J Clin Invest 2003; 33(suppl 2):1-5.